Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Ambio ; 43(1): 60-8, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24414805

RESUMO

Integrated sediment multiproxy studies and modeling were used to reconstruct past changes in the Baltic Sea ecosystem. Results of natural changes over the past 6000 years in the Baltic Sea ecosystem suggest that forecasted climate warming might enhance environmental problems of the Baltic Sea. Integrated modeling and sediment proxy studies reveal increased sea surface temperatures and expanded seafloor anoxia (in deep basins) during earlier natural warm climate phases, such as the Medieval Climate Anomaly. Under future IPCC scenarios of global warming, there is likely no improvement of bottom water conditions in the Baltic Sea. Thus, the measures already designed to produce a healthier Baltic Sea are insufficient in the long term. The interactions between climate change and anthropogenic impacts on the Baltic Sea should be considered in management, implementation of policy strategies in the Baltic Sea environmental issues, and adaptation to future climate change.


Assuntos
Mudança Climática , Ecossistema , Países Bálticos , Sedimentos Geológicos , Oceanos e Mares
2.
Neuron ; 48(2): 253-65, 2005 Oct 20.
Artigo em Inglês | MEDLINE | ID: mdl-16242406

RESUMO

Precursor cells of the embryonic cortex sequentially generate neurons and then glial cells, but the mechanisms regulating this neurogenic-to-gliogenic transition are unclear. Using cortical precursor cultures, which temporally mimic this in vivo differentiation pattern, we demonstrate that cortical neurons synthesize and secrete the neurotrophic cytokine cardiotrophin-1, which activates the gp130-JAK-STAT pathway and is essential for the timed genesis of astrocytes in vitro. Our data indicate that a similar phenomenon also occurs in vivo. In utero electroporation of neurotrophic cytokines in the environment of embryonic cortical precursors causes premature gliogenesis, while acute perturbation of gp130 in cortical precursors delays the normal timed appearance of astrocytes. Moreover, the neonatal cardiotrophin-1-/- cortex contains fewer astrocytes. Together, these results describe a neural feedback mechanism; newly born neurons produce cardiotrophin-1, which instructs multipotent cortical precursors to generate astrocytes, thereby ensuring that gliogenesis does not occur until neurogenesis is largely complete.


Assuntos
Diferenciação Celular/fisiologia , Córtex Cerebral/citologia , Citocinas/fisiologia , Neuroglia/fisiologia , Neurônios/fisiologia , Células-Tronco , Análise de Variância , Animais , Western Blotting/métodos , Contagem de Células/métodos , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Córtex Cerebral/embriologia , Fator Neurotrófico Ciliar/farmacologia , Contactinas , Meios de Cultivo Condicionados/farmacologia , Quinase 2 Dependente de Ciclina/metabolismo , Citocinas/deficiência , Citocinas/farmacologia , Interações Medicamentosas , Proteínas ELAV/metabolismo , Embrião de Mamíferos , Ativação Enzimática/fisiologia , Inibidores Enzimáticos/farmacologia , Flavonoides/farmacologia , Imunofluorescência/métodos , Proteína Glial Fibrilar Ácida/metabolismo , Proteínas de Fluorescência Verde/metabolismo , Receptores de Hialuronatos/metabolismo , Interleucina-6/farmacologia , Proteínas de Filamentos Intermediários/metabolismo , Fator Inibidor de Leucemia , Camundongos , Camundongos Transgênicos , Fatores de Crescimento Neural/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Nestina , Moléculas de Adesão de Célula Nervosa/metabolismo , Proteínas de Neurofilamentos/metabolismo , Organogênese , Fosfopiruvato Hidratase/metabolismo , Proteínas Tirosina Quinases/metabolismo , RNA Mensageiro/biossíntese , RNA Interferente Pequeno/farmacologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Subunidade beta da Proteína Ligante de Cálcio S100 , Proteínas S100/metabolismo , Fatores de Transcrição STAT/metabolismo , Células-Tronco/efeitos dos fármacos , Fatores de Tempo , Transfecção/métodos , Tubulina (Proteína)/metabolismo , Tirfostinas/farmacologia
3.
Thromb Haemost ; 92(6): 1201-6, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15583724

RESUMO

Clopidogrel is an effective and specific inhibitor of ADP-induced platelet aggregation. After metabolic activation, the active clopidogrel metabolite irreversibly impairs the human platelet P2Y12 ADP receptor. Gialpha-protein activation and inhibition of vasodilator-stimulated phosphoprotein (VASP) phosphorylation are two key elements of the P2Y12 receptor pathway suitable for quantitation of clopidogrel effects. So far, only limited data exist about a diminished responsiveness to clopidogrel and underlying possible mechanisms. We investigated clopidogrel effects in 57 patients after percutaneous coronary intervention and stent implantation by flow cytometry for the analysis of intracellular VASP phosphorylation. Patients were treated with a 300 mg clopidogrel loading dose, followed by 75 mg/day clopidogrel in combination with 100 mg/day aspirin. Samples were drawn after a median of 5 days of clopidogrel treatment. Considerable differences in the responsiveness to clopidogrel could be observed and it was shown that 17.5% (10/57) of the patients revealed an inadequate responsiveness to clopidogrel despite continuation of clopidogrel intake. Comparable amounts of Gialpha and VASP were found in two clopidogrel low-responding patients as well as in two responding patients. To exclude a molecular defect of P2Y12 ADP receptor, the P2Y12 receptor gene of eight clopidogrel treated patients (seven patients with inadequate responsiveness, one responder) was sequenced. We only found a single silent mutation in exon 2 at position 1828 (GA). We suggest that individual differences in clopidogrel metabolization could cause relevant variations in clopidogrel responsiveness despite the use of a 300 mg clopidogrel loading dose.


Assuntos
Angina Pectoris/terapia , Cardiopatias/terapia , Inibidores da Agregação Plaquetária/farmacologia , Ticlopidina/análogos & derivados , Ticlopidina/farmacologia , Difosfato de Adenosina/química , Difosfato de Adenosina/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Angioplastia Coronária com Balão/métodos , Aspirina/farmacologia , Moléculas de Adesão Celular/metabolismo , Clopidogrel , Quimioterapia Combinada , Feminino , Citometria de Fluxo , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/metabolismo , Cardiopatias/tratamento farmacológico , Humanos , Masculino , Proteínas de Membrana/antagonistas & inibidores , Proteínas dos Microfilamentos , Pessoa de Meia-Idade , Fosfoproteínas/metabolismo , Fosforilação , Ativação Plaquetária , Testes de Função Plaquetária , Estudos Prospectivos , Antagonistas do Receptor Purinérgico P2 , Receptores Purinérgicos P2Y12 , Stents , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA